Overview: Parechovirus Qualitative PCR TestIntroduction: The Parechovirus Qualitative PCR Test detects human parechovirus to diagnose infection, causing fever or neurological symptoms. Aligned with 2023 IDSA guidelines, it uses PCR for high specificity, supporting infectious disease screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in virology for patients with suspected parechovirus infection, particularly in infants.
Other Names: Parechovirus PCR Assay, Human Parechovirus Test.
FDA Status: Laboratory-developed test (LDT), meeting virology standards for diagnostic accuracy.
Historical Milestone: Parechovirus was identified in the 1950s. PCR-based testing improved in the 2000s, enhancing diagnostic precision for viral infections.
Purpose: Detects human parechovirus to diagnose infection, guides antiviral or supportive therapy, and evaluates patients with fever or neurological symptoms.
Test Parameters: 1. Human Parechovirus
Pretest Condition: No fasting required. Collect CSF, blood, stool, swab, or saliva at any time. Report symptoms like fever, neurological issues, or immunocompromised status.
Specimen: 1-2 mL CSF (sterile container), 2-5 mL whole blood (EDTA), 5-10 g stool (sterile container), 1-2 swabs (sterile swab/transport medium), or 1-2 mL saliva (sterile container). Transport in a biohazard bag within 2 hours.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document fever, neurological symptoms, or immunocompromised status (e.g., infancy, transplant). Include current medications, especially antivirals.
Consent: Written consent required, detailing the tests purpose, infection implications, and potential need for antiviral or supportive therapy.
Procedural Considerations: Uses PCR to detect parechovirus RNA. Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for pediatric or immunocompromised patients.
Factors Affecting Result Accuracy: Improper sample collection or contamination can affect results. Low viral load may reduce sensitivity.
Clinical Significance: Positive parechovirus confirms infection, guiding supportive or antiviral therapy. Negative results may require testing for other viral causes.
Specialist Consultation: Consult an infectious disease specialist or pediatrician for result interpretation and treatment planning.
Additional Supporting Tests: Enterovirus PCR, CSF analysis, or neuroimaging to assess viral infections.
Test Limitations: Limited to parechovirus; other viruses may cause similar symptoms. Clinical correlation is needed.
References: IDSA Pediatric Infection Guidelines, 2023; Journal of Clinical Virology, Harvala H, 2022.
